Catalyst Biosciences, Inc.
(NASDAQ : CBIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading CBIO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.91%73.380.9%$725.47m
AMGNAmgen Inc.
0.75%180.521.1%$595.42m
CELGCelgene Corporation
1.37%136.851.1%$589.74m
REGNRegeneron Pharmaceuticals, Inc.
2.73%520.632.7%$544.84m
BIIBBiogen Inc.
0.70%283.921.2%$408.27m
VRTXVertex Pharmaceuticals Incorporated
-0.03%159.641.9%$370.01m
ALXNAlexion Pharmaceuticals, Inc.
1.77%129.551.9%$285.53m
CLVSClovis Oncology, Inc.
4.08%87.2718.0%$176.00m
TSROTESARO, Inc.
3.37%128.2014.7%$169.77m
INCYIncyte Corporation
1.81%132.812.6%$169.51m
ILMNIllumina, Inc.
-0.34%173.293.5%$159.29m
EXELExelixis, Inc.
2.09%27.316.5%$156.56m
BMRNBioMarin Pharmaceutical Inc.
0.62%87.774.4%$131.86m
KITEKite Pharma, Inc.
2.36%107.9216.1%$122.46m
BLUEBluebird Bio, Inc.
0.62%97.9019.3%$118.03m

Company Profile

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel medicines to address hematology indications. It offers next generation hemostasis programs and anti-complement assets. The company was founded on August 5, 2002 and is headquartered in South San Francisco, CA.